2 27 *1/*28, 2% (2) had *1/*36 and 7% (7) showed *28/*28. There was no preferential sex 28 distribution.
29
Since most Argentinians are of Caucasian descent, a European genotype frequency profile is to 30 be expected. That is evident in the wild type prevalence in our population. However, the 31 contribution of Native American ancestry to gene pool components may in part explain the 32 higher prevalence of the *28 genotype in UGT1A1 *1 in our population, in comparison with Gilbert syndrome may be more susceptible to the toxic effect of substances that require 77 bilirubin-UGT-mediated hepatic glucuronidation prior to excretion. Gilbert syndrome is known to 78 increase the risk of drug toxicity with irinotecan and the hyperbilirubinemia associated with 79 atazanavir(2,7).
80
The active metabolite of irinotecan, SN-38, is glucuronized in the liver mainly by bilirubin-UGT.
81
The major dose-limiting toxicity of this drug is diarrhoea.In patients who inherit certain UGT1A1 82 polymorphisms, reduced glucuronidation of SN-38 leads to an increased incidence of diarrhoea.
83
The symptoms can be severe enough to warrant switching to other drugs. Thus, it is currently 84 recommended to test the UGT1A1 polymorphism prior to the administration of Irinotecan and to 85 adjust the dose according to the resulting genotype(8).
86
As previously stated, some drugs may induce hyperbilirubinemia in patients with Gilbert 87 syndrome. Atazanavir, an antiretroviral medication, is an inhibitor of bilirubin-UGT activity and is 88 associated with hyperbilirubinemia(9). Isolated hyperbilirubinemia has also been reported during 89 the treatment of hepatitis C with peginterferon and ribavirin and in patients receiving pazopanib.
90
In such cases, discontinuation of therapy is usually not necessary(10).
91
The incidences and types of the polymorphisms for these enzymes are quite different according 92 to geographical regions and ethnic groups. 
124
The genotyping of all samples was according to the method previously described. Among 125 the 100 subjects analysed, 49% (49) were male and 51% (51) were female with a median age 126 of 43 and a range of 32-80 years.
127
In our population, the distribution of UGT1A1 was - Figure 1 attached separatedly-: 70.5% 128 (70.5) for the *1 allele, 21.5% for the *28 allele and 1% for the *36 allele. 48% (48) presented 129 the *1/*1 genotype, while 43 % (43) had *1/*28, 2% (2) had *1/*36 and 7% (7) showed *28/*28.
130
No preferential sex distribution was observed between genotypes.
DISCUSSION

132
UGT 1A1 is the major UGT isoform responsible for glucuronidation of bilirubin in human liver, in a vast country that has a longstanding history of racial mixture.
159
Understanding these polymorphisms and the characterization of these in different populations is 160 essential for the prevention of adverse effects of a considerable number of drugs and also for 161 the reduction of cancer-associated risks.
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